News Roundup: June 13 to June 17
Your weekly roundup of the latest news from Drug Topics®.
Next-In-Class Treatments Lead Oncology Drug Pipeline Update
The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.
Hacking Diabetes: The DIY Bionic Pancreas Is Here to Stay
A do-it-yourself option to replace traditional diabetes management technology is growing in popularity.
Craving Connection, Pharmacists Celebrate a Return to In-Person Events
Transformation was top of mind at the 2022 American Associated Pharmacies (AAP) Annual Conference, where industry leaders, pharmacy owners, and AAP staff came together to celebrate their first annual meeting—live and in-person—since 2019.
FDA Approves Baricitinib Oral Tablets as First Systemic Alopecia Areata Treatment
The drug has previously been approved to treat moderately to severely active rheumatoid arthritis.
Integrated Health System Pharmacy Models Associated With Medication Adherence, Fewer Side Effects
Patient reported outcomes for were positive for those who filled medications at an integrated health system specialty pharmacy.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
